the

of
Republic of the Philippines
Department of Health
OFFICE OF THE SECRETARY
TN 30 an
ADMINISTRATIVE ORDER :

No. 2022 - D0I8

SUBJECT: Utilization

per
Omnibus
Guidelines

Lifestage :

and
I. RATIONALE

In line with the constitutional mandate to protect and promote the health of Filipinos
and pursuant to Executive Order (EO) No. 102 series of 1999, followed by EO No.
366 series of 2004, the Department of Health (DOH), as the national technical
authority on health, seeks to establish the highest achievable standards of quality
health care, health promotion and health protection, on which local government units

Health
(LGUs), non-government organizations (NGOs), other private organizations, and
individual members of civil society will anchor their health programs and strategies.

Cognizant of the numerous policies on individual-based and population-based health

services that the DOH has issued in the past decades, there have been challenges in

Development
the adoption, implementation, and utilization by the LGUs and government and
non-government health care providers in terms of health systems planning and service
delivery. Acknowledging the necessary resource requirements to adopt a
whole-of-system, whole-of-government, and whole-of-society approach in the
development of quality standards for clinical care for existing and emerging diseases,
conditions, and disorders in all life stages and settings, there is a need to integrate
existing policies on health services and to gradually incorporate and update standards
across the entire spectrum of clinical care.

Strengthened by the enactment of the Republic Act (RA) No. 11223, also known as
the “Universal Health Care (UHC) Act”, current health reforms aim to provide an
integrated and comprehensive set of quality and cost-effective services covering the
spectrum of care from promotion, prevention, screening, diagnosis, treatment,
rehabilitation, and palliation, and transform the health system focus from curative and
hospital care to a primary care-oriented and people-centered care. With this, the DOH
is mandated to institutionalize the process of standards setting for service delivery and
to strengthen efforts to provide a comprehensive and coordinated approach to health.

The Omnibus Health Guidelines (OHG) per Lifestage are hereby developed to serve
as the overarching policy issuance integrating key policy provisions governing
various health programs and integrating various standards: of care. These guidelines
shall provide a life course approach for the delivery of services appropriate to each
Filipino and guide the functional and efficient linking of health services across
different levels of care, different care settings, and across the entire spectrum of care,
with primary care as the foundation, and intersectoral participation as a key principle.

Building 1, San Lazaro Compound, Rizal Avenue, Sta. Cruz, 1003 Manila ® Trunk Line 651-7800 local 1113, 1108, 1135
Direct Line: 711-9502; 711-9503 Fax: 743-1829 e URL: http://www.doh.gov.ph; e-mail: [email protected].,ph

V &
II. OBJECTIVES

This Administrative Order (AO) aims to:

A. Provide guidance on an integrated and consolidated approach to health service
delivery across various life stages, across the continuum of care - from health
promotion, prevention, screening, diagnosis, treatment, rehabilitation, to
in
palliation, various settings and levels of care; and
B. Define the uses and process of updating the coverage of the OHG.

IIL SCOPE

This Order shall apply to all DOH Central Office Bureaus and Services, Centers for
Health Development (CHDs), including the Ministry of Health - Bangsamoro
Autonomous Region in Muslim Mindanao (BARMM) subject to the applicable
provisions of RA No. 11054 or the “Bangsamoro Organic Act” and subsequent rules
and policies issued by the Bangsamoro government, DOH-retained hospitals, public
and private hospitals, treatment and rehabilitation centers, other health facilities,
LGUs, partners from national government agencies (NGAs), development partners,
civil society organizations (CSOs) including NGOs, community-based organizations
(CBOs), advocacy groups, the academe, and all other stakeholders concerned.

IV. DEFINITION OF TERMS

A. Clinical Practice Guidelines (CPG) - refer to evidence-based recommendations

used to optimize patient care by reducing variations in practice and ensuring
efficient use of resources, which are informed by a systematic review of evidence
and an assessment of the benefits and harms of alternative care options. (Institute
of Medicine, 2011).

B. Continuum of Care - refers to the entire spectrum of health services, including

promotive, preventive, screening, diagnostic, curative, palliative, and
rehabilitative services.

C. Guideline Implementation Tools - refer to tools that promote awareness and

utilization of guidelines, such as but not limited to Clinician Support Tools (e.g.
algorithms, flowcharts, clinical pathways, checklists), Patient Support Tools (e.g.
guideline summary for patients, self-management support tools), Implementation
Support Tools (e.g. manuals, human, infrastructure. and funding resources), and
Evaluation Support Tools (e.g. audit tools, quality indicators, and performance
measures) (Liang et al, 2017).

D. Lifestage — refers to a phase in a person’s lifespan from infancy to advanced

age
that presents with specific health needs and concerns. For the purposes of this
policy, the specific lifestage of a person is defined as follows:
to
1. Child - refers a person from newborn to below 10 years of age.
2. Adolescent - refers to a person between the ages of 10 to 19 years of age who
is in transition from childhood to adulthood. (RA No. 10354 “The
Responsible Parenthood and Reproductive Health Act of 2012”).
3. Women of Reproductive Age - refers to women (female sex) between 15 to

Bs
 49 years of age.
4. Adult - refers to an individual aged 20 years to 59 years and 11 months.
5. Elderly or Senior Citizen - refers to a person at least 60 years old (RA No.
9994 “Expanded Senior Citizens Act of 2010”).

. Levels of Care - refer to the different types of facilities that deliver health
services, including primary care services, intermediate care services, and
specialized care services, guided by the Resource Stratified Frameworks in the
Philippine Health Facility Development Plan (PHFDP) 2020-2040 (DOH, 2020).

. Life Course Approach - refers to an approach that recognizes that all stages of a
person’s life are intricately intertwined with each other, with the lives of other
people in society, and with past and future generations of their families; that
health and well-being depend on interactions between risk and protective factors
throughout people’s lives; and that takes action early to ensure the best start in
life, appropriately to protect and promote health during life’s transition periods,
and together, as a whole society, to create healthy environments, improve
conditions of daily life, and strengthen people-centered health systems (World
Health Organization, 2018).

. National Practice Guidelines (NPG) - refer to DOH-endorsed CPGs, standard

treatment guidelines, evidence-based guidelines, or any equivalent standard that
sets how individuals should be given care and that meets all quality requirements
as stipulated in the Appraisal of Guidelines Research and Evaluation II (AGREE
II) (DOH Administrative Order No. 2021-0020 “Revised Guidelines on National
Practice Guideline Development, Adoption and Dissemination”).

- Primary care - refers to initial-contact, accessible, continuous, comprehensive,

and coordinated care that is accessible at the time of need including a range of
services for all presenting conditions, and the ability to coordinate referrals to
other healthcare providers in the health system, when necessary (RA No. 11223).

Primary care provider - refers to a health care worker, with defined

competencies, who has received certification in primary care as determined by
the DOH or any health institution that is licensed and certified by the DOH (RA
No. 11223 Implementing Rules and Regulations or IRR).

Primary care facility - refers to an institution that primarily delivers primary

care services which shall be licensed or registered by the DOH (RA No. 11223
IRR).

. Quality appraisal - refers to the methodological review of assessing the quality

of reporting of clinical practice guidelines and assessing the results and data from
research studies by applying the rules of evidence to factors such as directness
and validity, among others. This usually involves the use of explicit and
transparent methods and or tools such as the AGREE II too! and critical appraisal
tools for CPGs and research studies, respectively (DOH Administrative Order
No. 2018 - 0019: Guidelines on the Institutionalization and Implementation of
the National Clinical Practice Guidelines Program; DOH-PhilHealth, 2018).
 L. Settings-based care - refers to the interventions that integrate multiple,
interacting components to create supportive environments for optimal health to
minimize risk factors and conditions that contribute to disease (Neufeld &
Kettner, 2022).

. Standards of care (SOCs) - refer to specific actions, interventions, or processes,

which are based on the best available medical evidence and are needed to 1)
deliver safe, effective, and patient-centered care, and 2) achieve optimal health
outcomes. SOCs shall be identified along the continuum of care, specifically (1)
prevention, (2) screening (for well or asymptomatic individuals), (3) diagnosis
(testing in sick individuals), (4) treatment (including medications and
procedures), (6) palliation, and (7) rehabilitation.

V. GENERAL GUIDELINES

A. The OHG shall be the main policy reference in the fulfillment of the mandate of
DOH in setting standards of care to ensure the safety and quality of health
services, based on CPGs and best available evidence, in cooperation with
professional societies and the academe, as outlined in Section 27 of the UHC
Act.

. The OHG shall define the standards of care using the life course approach in the
provision of individual- and population-based services, along the continuum of
care, in health facilities and settings.

The OHG shall be developed and continuously updated through a

whole-of-system, whole-of-government and whole-of-society approach, wherein
all members of the government and society, in solidarity, are encouraged to
participate and act in order to achieve its collective goals and objectives.

The OHG shall be updated every three years or as necessary based on new
evidence, new policy directions, and stakeholder and client feedback. Updates
shall be prioritized, if necessary, based on strength of evidence, burden of
disease, and practice variation. The evidence to be considered in the periodic
updating of the OHG shall include the following: recommendations from NPGs
and international high-quality CPGs, high-quality research studies, and
supplementary references that pass quality appraisal, which address conditions
that contribute significantly to the burden of disease per life stage.

The OHG shall be developed with a focus on primary care service delivery, and
progressively expanded to include standards for intermediate and specialized
care, in order to guide integrated service delivery across different levels of care.

The OHG shall be used as the main reference for developing guidance to
individuals and households on self-care and household care; healthcare providers
for clinical care; LGUs and primary care managers for community-based care;
settings-based managers for care in schools, workplaces. or closed settings; and
NGA for national policies and incentives on quality health service delivery.

G. The OHG and quality appraised CPGs shall be considered in the development of
 health entitlements and expansion of benefit packages, but shall not replace the
established processes for prioritization and evaluation by the Health Technology
Assessment Council (HTAC) and the Philippine Health Insurance Corporation
(PhilHealth).

H. All individuals involved in the development of the OHG shall declare their
conflicts of interest, including those related to breast milk substitutes, tobacco,
vapor products, heated tobacco products, alcoholic beverages, and
pharmaceutical products, in accordance with the National Code of Marketing of
Breastmilk Substitutes, Breastmilk Supplements, and Other Related Products
(EO No. 51 series of 1986), Protection of the Bureaucracy Against Tobacco
Industry Interference (Civil Service Commission-DOH Joint Memorandum
Circular No. 2010-001), Implementing Guidelines of Section 35 of the Republic
Act No. 11223, otherwise known as the “Universal Health Care Act’, on
Standards on Receipt, Assessment, and Management of Conflict of Interest
(DOH AO No. 2021-0011), Adoption and Implementation of “The Mexico City
Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical
Sector” (Food and Drug Administration Circular No. 2013-024), and other
relevant laws, policies and guidelines.

I. This AO shall not preclude the DOH from releasing new policies on health
service delivery and implementation, particularly in the context of disasters and
public health emergencies. The relevant provisions in new policies shall be
included in the updates of the OHG.

VI. SPECIFIC GUIDELINES

A. Technical Working Group Establishment and Stakeholder Consultation

I. The DOH - Disease Prevention and Control Bureau (DPCB) shall provide
direction and oversight on the development and updating of the OHG and
shall ensure the declaration, assessment, and appropriate management
of
the
interests of all individuals involved in the development and updating of the
OHG.

2. The DPCB shall regularly convene, at least biannually or as frequently as

necessary, a Technical Working Group (TWG), which shall include
representatives from DOH Offices, Medical and Professional Societies,
Allied Health Professional Organizations, and other relevant stakeholders,
whose clinical expertise and/or experiences are relevant to each lifestage. The
TWG shall review, provide comments, and recommend technical inputs in the
development and updating of the OHG and Guideline Implementation Tools.

3. The DOH may invite additional external experts to review and provide
comments and technical inputs on topics that are beyond the expertise of the
TWG.

4. The DOH shall invite other relevant stakeholders such as the representatives
of other government agencies, NGOs, clinical experts, community leaders,

Cy
)
 representatives of marginalized and underprivileged sectors, and the public,
among others, to review and provide inputs on the OHG.

B. Development, Updating and Utilization of the OHG

I. The initial version of the OHG shall include SOCs from existing policies,
which are valid, evidence-based, and consistent with UHC principles, and
supplemented by quality local and international CPGs and other quality
references, which are consistent with the best available evidence and
international standards.

The DPCB shall perform rational priority setting in developing and updating
the OHG based on the following criteria: burden of disease including
magnitude, severity, and urgency; new or emerging evidence that passed
quality appraisal; presence of practice variation; and stakeholder feedback.

Standards of care shall be derived from the recommendations of

quality-appraised local and international CPGs, research studies, other
evidence-based references, relevant laws, and evidence-based policies. All
evidence sources utilized in the development and updates of the OHG shall be
subjected to a quality appraisal process, using internationally validated and
accepted appraisal tools. References that pass quality appraisal shall be
utilized in updating the OHG.

The OHG per life stage and setting shall be issued as Department Circulars
and divided as follows:
Omnibus Health Guidelines for Children
oe
Omnibus Health Guidelines for Adolescents
Omnibus Health Guidelines for Adults
oe Omnibus Health Guidelines for the Elderly
Omnibus Health Guidelines for Managers of Various Settings

The OHG shall be translated into user-friendly Guideline Implementation

Tools for the following target users, and shall be released through appropriate
to
policy issuances, in order facilitate their implementation and utilization:
a. Clinician Support Tools for Primary Care Providers and other
healthcare professionals (e.g. algorithms, checklists, handbooks) to
guide clinical service delivery;
b. Patient Support Tools (e.g. guideline summaries, self-management
support tools) for individual Filipinos to guide self and household care;
and
c. Implementation Support Tools (e.g. manuals) and Evaluation Support
Tools (e.g. audit tools, performance measures) for LGUs,
Provincial/City/Municipal Health Officers, Primary Care Managers,
and Settings-based Managers.

The monitoring and evaluation of the OHG shall be led by DPCB and shall be
a shared responsibility of all stakeholders involved in its implementation,
including the different DOH offices and attached agencies, CHDs, LGUs,
other concerned NGAs, schools and other learning institutions, workplaces,
 development partners, academic and health professional partners, and other
CSOs. The DPCB shall gather inputs on accomplishments or feedback from
the respective mandated offices and stakeholders or their representatives, as
listed in Section VII. Further guidelines on the methodologies of monitoring
and evaluation, and other related details shall be provided by DPCB through a
separate issuance.

VII. ROLES AND RESPONSIBILITIES

Specific roles and responsibilities shall be established in consideration of devolution

and reassignment of roles and functions to different levels of the government.

A. The DPCB shall lead the development and regular updating of the OHG based
on the latest available evidence. Additionally, the DPCB shall:
1. Scope, appraise, review, and synthesize evidence to formulate
evidence-based provisions of the OHG;
2. Conduct capacity building and strengthening activities on evidence
synthesis and knowledge translation;
3. Coordinate the formation, internal proceedings, and external relations of
the TWG;
Facilitate the declaration, assessment, and management of conflicts of
interests of all individuals involved in the OHG development and
updating;
Develop and disseminate Guideline Implementation Tools, particularly
Clinician Support Tools (algorithms, clinical pathways, flowcharts, forms,
and checklists), Implementation Support Tools (manuals, human,
infrastructure and funding resources), and Evaluation Support Tools
(audit tools, quality indicators, performance measures), based on the
OHG;
6. Ensure the dissemination and advocate the adoption and implementation
of the OHG and Guideline Implementation Tools by target users; and
7. Lead the monitoring and evaluation of the implementation of the OHG.

B. The Health Policy and Development and Planning Bureau (HPDPB) shall
ensure alignment of the OHG to the general thrusts and directions of the DOH.

C. The Bureau of Local Health Systems Development (BLHSD) shall:

1. Provide policy directions on local health systems development especially
on strategic and investment planning; and
2. Facilitate the monitoring of effectiveness and efficiency of LGUs in
implementing health programs and managing health systems through the
LGU Health Scorecard and Local Health Systems Maturity Level, among
others.

D. The Health Promotion Bureau (HPB) shall:

I. Lead the development and coordination of policies, strategies, programs,
and activities in various settings related to the promotion of health and
increasing health awareness and literacy in the health promotion priority
areas as stated in the OHG and in accordance with the Health Promotion
Framework Strategy; and
 2. Develop and disseminate Patient Support Tools, based on the provisions
of the OHG, such as but not limited to OHG summaries, self-management
tools (e.g. templates, action plans), and other health information,
education, and advocacy materials, in collaboration with DPCB.

The Health Facilities and Services Regulatory Bureau (HFSRB) shall use the
OHG
as
one of itsreferences in setting the scope of services and the standards for
the licensing of health facilities and services.

The Health Human Resource Development Bureau (HHRDB) shall lead

initiatives to include the provisions of the OHG in Health Human Resource
standards, capacity building, assistance, and networking, and utilize it to guide
the development of integrated modules for primary care service delivery. The
HHRDB shall advocate the utilization of OHG in the certification of
professionals by the Professional Regulation Commission.

. The Health Facility Development Bureau (HFDB) shall align plans, policies
and strategies relative to the health facility development, planning, operation, and
maintenance with the provisions of the OHG.

The Health Emergency Management Bureau (HEMB) shall align the

protocols, guidelines and standards for disaster risk reduction and management in
health (DRRM-H) with the provisions of the Omnibus Health Guidelines, with
emphasis on health emergency preparedness and response.

The Health Technology Assessment Division (HTAD) and the Health

Technology Assessment Council (HTAC) shall continue to utilize all available
evidence, including the standards of care in the OHG, incorporating economic
assessments and ethical, legal, social and health systems impact (when
applicable), as reference in the implementation of the HTA process.

J. The Food and Drug Administration (FDA) shall:

1. Align plans, standards, and policies for the regulation of products with the
provisions of the OHG.
2. Prioritize the assessment and regulation of laboratory tests, medications,
supplements, and other relevant products included in the OHG.

K. The PhilHealth shall use the OHG for prioritizing the costing of services and
designing benefit packages, with due consideration given to the HTA process.

L. The Centers for Health Development (CHD) shall:

1. Participate in the stakeholder consultation of the OHG and Guideline
Implementation Tools and regularly provide stakeholder feedback on the
applicability, contextualization, and implementation of the OHG in the
local setting; and
2. Oversee the widest dissemination, monitor implementation, and provide
technical assistance to the identified stakeholders within their
geographical areas of jurisdiction, particularly in the adoption of the OHG
in clinical practice, formulation of LGU policies, and incorporation of the
OHG as a reference in related local planning tools, such as the Local
 Investment Plan for Health.

M. The LGUs are enjoined to:

1. Adopt the OHG through the enactment into local issuances and ensure its
implementation;
2. Utilize the provisions of the OHG in their strategic, investment, and
operational planning; and
3. Implement quality assurance mechanisms and ensure continuous quality
improvement for all health care providers and facilities within their area
of jurisdiction.

N. Other NGAs are enjoined to align their policies, programs and services with the
OHG.

O. The Medical Societies and Allied Health Professional Organizations are

enjoined to:
I. Develop high-quality CPGs and researches that impact policy and
participate in quality assurance and improvement mechanisms;
2. Provide technical inputs and comments in the development of the OHG
and Guideline Implementation Tools;
3. Support the dissemination, advocacy, and implementation of the OHG
and Guideline Implementation Tools; and
4. Support the monitoring and evaluation of the OHG.

P. The Development Partners and CSOs are enjoined to:

I. Participate in stakeholder consultations and regularly provide stakeholder
feedback;
2. Provide inputs on the applicability, contextualization, and implementation
of the OHG in the local setting; and
3. Support the dissemination, implementation, monitoring and evaluation of
the OHG.

Q. Learning Institutions are enjoined to:

1. Participate in stakeholder consultations and regularly provide stakeholder
feedback; and
2. Include the relevant provisions of the OHG in their educational curricula
and facilitate their implementation.

R. Workplaces are enjoined to facilitate the inclusion of the provisions of the OHG
as part of the services in occupational health.

S. Members of the private health sector are enjoined to align their policies,
programs, and services to the OHG.

VIII REPEALING CLAUSE

Relevant provisions or parts of issuances listed in Annex A and all other related
issuances that are inconsistent with this Administrative Order are hereby amended,
modified or repealed by succeeding Omnibus Health Guidelines to be released as
Department Circulars.
IX. SEPARABILITY CLAUSE

If any clause, sentence, or provision of this Order shall be declared invalid or

unconstitutional, the other provisions not affected thereby shall remain valid and
effective.

EFFECTIVITY

This Order shall take effect immediately fifteen (15) days after publication to the
Official Gazette or in any newspaper of general circulation.

Arranc CO T. DUQUE III, MD, MSc

Secretary of Health

10
 References

Civil Service Commission - Department of Health Joint Memorandum Circular No. 2010-01.
Protection of the Bureaucracy Against Tobacco Industry Interference.

Department of Health. (2018). Administrative Order No. 2018 - 0019 Guidelines on the
Institutionalization and Implementation of the National Clinical Practice Guidelines
Program.

Department of Health & Philippine Health Insurance Corporation. (2018). Manual for
Clinical Practice Guidelines Development.

Department of Health. (2020). Philippine Health Facility Development Plan (PHFDP) 2020-
2040.
https://doh.gov.ph/sites/default/files/publications/DOH_PHILIPPINE%20HEALTH%
20FACILITY %20DEVELOPMENT%20PLAN%202020 2040
0.pdf
Department of Health. (2021). Administrative Order No. 2021-0011 Implementing Guidelines
of Section 35 of the Republic Act No. 11223, otherwise known as the “Universal Health
Care Act’, on Standards on Receipt, Assessment, and Management of Conflict
of
Interest.

Department of Health. (2021). Administrative Order No. 2021 - 000]] Implementing

Guidelines of Section 35 of the Republic Act No. 11223, otherwise known
as the
“Universal Health Care Act’, on Standards on Receipt, Assessment, and
Management
of Conflict of Interest

Department of Health. (2021). Administrative Order No. 2021-0020 Revised Guidelines

on
National Practice Guideline Development Adoption and Dissemination.

Executive Order No. 51, s. 1986. Adopting a National Code of Marketing

of Breastmilk
Substitutes, Breastmilk Supplements and Related Products, Penalizing Violations
Thereof, and for Other Purposes

Executive Order No. 102, s. 1997. Redirecting the Functions and Operations of the
Department of Health.

Executive Order No. 366, s. 2004. Directing a Strategic Review of the

Operations and
Organizations of the Executive Branch and Providing Options and Incentives for
Government Employees who may be affected by the Rationalization
of the Functions
and Agencies of the Executive Branch

Food and Drug Administration. (2013). FDA Circular No. 2013-024

Adoption and
Implementation of “The Mexico City Principles for Voluntary Codes of Business Ethics
in the Biopharmaceutical Sector”.

Institute of Medicine. (2011). Clinical Practice Guidelines We Can Trust.

Washington, DC:
The National Academies Press.

CL
Liang, L., Abi Safi, J., Gagliardi, A., Armstrong, M., Bernhardsson, S., Brown, J., Chraborty,
S., Fleuren, M., Lewis, S., Lockwood, C., Pardo-Hernandez, H., Vemnooij, R., &
Willson, M.. (2017). Number and type of guideline implementation tools varies by
guideline, clinical condition, country of origin, and type of developer organization:
content analysis of guidelines. Implementation Sci 12, 136.
https://doi.org/10.1186/513012-017-0668-7

Neufeld, J. & Kettner, J. (2014). The Settings Approach in Public Health: Ti hinking about
Schools in Infectious Disease Prevention and Control. Purple Paper 45.
https://nccid.ca/wp-content/uploads/sites/2/2015/03/ PP_45 EN.pdf

Republic Act No. 9994: An Act Granting Additional Benefits and Privileges to Senior Citizens,
Further Amending Republic Act No. 7432, As Amended”

Republic Act No. 10354: The Responsible Parenthood and Reproductive Health Act 2012”
of
Republic Act No. 11054: An Act Providing for the Organic Law for the Bangsamoro
Autonomous Region in Muslim Mindanao

Republic Act No. 11223: An Act Instituting Universal Health Care Jor All Filipinos,
Prescribing Reforms in the Health Care System, and Appropriating Funds Therefore”
and its Implementing Rules and Regulations

World Health Organization. (2018). The life-course approach: from theory to

practice. Case
stories from two small countries in Europe.
https://www.euro.who.int/__data/assets/pdf file/0004/374359/life-course-iceland-
malta-eng.pdf

ii
ANNEX A: LIST OF POLICIES WITH AMENDED PROVISIONS

Department of Health (2007). Administrative Order No. 2007-0045 “Zinc Supplementation

and Reformulated Oral Rehydration Salt in the Management of Diarrhea Among
Children”

Department of Health (2008). Administrative Order No. 2008-0201 “Strategy for the
Maternal Newborn Child Health and Nutrition (MNCHN)”

Department of Health (2009). Administrative Order No. 2009-0025 “Adopting New Policies
and Protocol on Essential Newborn Care”

Department of Health (2009). Administrative Order No. 2009-0027 “Amendment to AO

2007-0029 re: Revised Guidelines on Management of Animal Bite Patients”

Department of Health (2010). Administrative Order No. 2005-0014 “National Policies on

Infant and Young Child Feeding”

Department of Health (2010). Administrative Order No. 2010-0023 “Guidelines on

Deworming Drug Administration and the Management of Adverse Events Following
Deworming (AEFD)”

Department of Health (2012). Administrative Order No. 2012-0029 “Implementing

Guidelines on the Institutionalization of Philippine Package of Essential NCD
Interventions (PhilPEN) on the Integrated Management of Hypertension and Diabetes
Jor Primary Health Care Facilities”
Department of Health (2016). Administrative Order No. 2016-0014 “Implementing
Guidelines on the Organization of Health Clubs for Patients with Hypertension and
Diabetes in Health Facilities”

Department of Health (2016). Administrative Order No. 2016-0035 “Guidelines on the

Provision of Quality Antenatal Care in All Birthing Centers and Health Facilities
Providing Maternity Care Services”

Department of Health (2017). Administrative Order No. 2017-0012 “Guidelines on the

Adoption of Baseline Primary Health Care Guarantees for All F ilipinos”

Department of Health (2019). Administrative Order No. 2019-0026 “National Policy in the
Provision of Birthing Assistance to Primigravid and Grand Multigravid Women”

Department of Health (2020). Administrative Order No. 2020-0040 “Guidelines on the

Classification of Individual-based and Population-based Primary Care Service
Packages”